bioRxivBioinformaticsPreprint
Predicting long-term multicategory cause of death in patients with prostate cancer: random forest versus multinomial model
Jianwei WangiD, Fei DengiD, Fuqing ZengiD, A. Shanahan, Wei Vivian LiiD, Lanjing ZhangiD
Abstract
Patients with prostate cancer more likely die of non-cancer cause of death (COD) than prostate cancer. It is thus important to accurately predict multi-category COD in these patients. Random forest (RF), a popular machine learning model, has been shown useful for predicting binary cancer-specific deaths. However, its accuracy for predicting multi-category COD in cancer patients is unclear. We included patients in Surveillance, Epidemiology, and End Results-18 cancer registry-program with prostate cancer diagnosed in 2004 (followed-up through 2016). They were randomly divided into training and testing sets with equal sizes. We evaluated prediction accuracies of RF and conventional-statistical/multinomial models for 6-category COD by data-encoding types using the 2-fold cross-validation approach. Among 49,864 prostate cancer patients, 29,611 (59.4%) were alive at the end of follow-up, and 5,448 (10.9%) died of cardiovascular disease, 4,607 (9.2%) of prostate cancer, 3,681 (7.4%) of Non-Prostate cancer, 717 (1.4%) of infection, and 5,800 (11.6%) of other causes. We predicted 6-category COD among these patients with a mean accuracy of 59.1% (n=240, 95% CI, 58.7%-59.4%) in RF models with one-hot encoding, and 50.4% (95% CI, 49.7%-51.0%) in multinomial models. Tumor characteristics, prostate-specific antigen level, and diagnosis confirmation-method were important in RF and multinomial models. In RF models, no statistical differences were found between the accuracies of development versus cross validation phases, and those of categorical versus one-hot encoding. We here report a RF model that has an accuracy of 59.1% in predicting long-term 6-category COD among prostate cancer patients. It outperforms multinomial logistic models (absolute prediction-accuracy difference, 8.7%).
- Citations
- 18
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Random forest-based modelling to detect biomarkers for prostate cancer progression
R. Toth, H. Schiffmann, … C. Gerhauser·bioRxiv·Apr 8, 2019
- A Machine Learning Approach for Long-Term Prognosis of Bladder Cancer based on Clinical and Molecular Features
Qingyuan Song, John D. Seigne, … Saeed Hassanpour·bioRxiv·Dec 4, 2019
- Prediction of prostate cancer by deep learning with multilayer artificial neural network.
Takumi Takeuchi, M. Hattori, … Koji Mikami·Canadian Urological Association JournalPeer-reviewed·Oct 15, 2018
- Artificial Intelligence Helps to Predict Recurrence and Mortality for Prostate Cancer using Histology Images
O. Eminaga, F. Saad, … S.-R. Leyh-Bannurah·bioRxiv·Jul 27, 2023
- A hybrid mortality prediction model of patients with cavitary pulmonary carcinomas
Maliazurina Binti Saad·bioRxiv·Jun 11, 2018
- Comprehensive evaluation of machine learning models and gene expression signatures for prostate cancer prognosis using large population cohorts
Ruidong Li, Jianguo Zhu, … Zhenyu Jia·Cancer ResearchPeer-reviewed·Mar 31, 2022